US Patent Issued to Amgen on May 13 for "Methods of treating graft versus host disease using IL-2 muteins" (California, Washington Inventors)

ALEXANDRIA, Va., June 12 -- United States Patent no. 12,297,248, issued on May 13, was assigned to Amgen Inc. (Thousand Oaks, Calif.).

"Methods of treating graft versus host disease using IL-2 muteins" was invented by Marc A. Gavin (Vashon, Wash.) and Li Li (San Bruno, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Described herein are immunosuppressive molecules including immunosuppressive variants of IL-2, and use of such molecules to treat inflammatory and autoimmune disorders."

The patent was filed on Dec. 20, 2022, under Application No. 18/068,970.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u...